Nabriva Therapeutics plc Annual Return On Assets in % from 2017 to 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nabriva Therapeutics plc quarterly/annual Return On Assets history and growth rate from 2017 to 2022.
  • Nabriva Therapeutics plc Return On Assets for the quarter ending June 30, 2023 was -192 %, a 199% decline year-over-year.
  • Nabriva Therapeutics plc annual Return On Assets for 2022 was -114 %, a 98.7% decline from 2021.
  • Nabriva Therapeutics plc annual Return On Assets for 2021 was -57.4 %, a 54.3% increase from 2020.
  • Nabriva Therapeutics plc annual Return On Assets for 2020 was -126 %, a 41.1% decline from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -114 -56.6 -98.7% Jan 1, 2022 Dec 31, 2022
2021 -57.4 +68.3 +54.3% Jan 1, 2021 Dec 31, 2021
2020 -126 -36.6 -41.1% Jan 1, 2020 Dec 31, 2020
2019 -89 +22.9 +20.5% Jan 1, 2019 Dec 31, 2019
2018 -112 -29.8 -36.2% Jan 1, 2018 Dec 31, 2018
2017 -82.2 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.